核向的化学酸纳米棒通过局部DNA损伤和STING激活来增强先天的抗瘤免疫力
概括
核向纳米棒 (PFPD) 通过引起DNA损伤和STING通路激活来激活天生的免疫力. 这种策略通过增强自然杀手和T细胞反应,有效地根除瘤.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 干扰素基因刺激器 (STING) 途径是增强抗瘤免疫力的有希望的目标.
- 加强用于癌症治疗的STING通路存在重大挑战.
研究的目的:
- 开发核向的化学纳米棒 (PFPD),用于局部DNA损伤和STING激活.
- 增强先天的抗瘤免疫力,以有效的全身瘤治疗.
主要方法:
- PFPD纳米棒是使用光敏感剂和向核的质制造的,装有刺痛激动剂DMXAA.
- 光照射诱导反应性氧物种 (ROS) 导致核DNA损伤,释放细胞质DNA碎片.
- 释放的DNA片段,以及STING激动剂,激活了先天的抗瘤免疫力.
主要成果:
- PFPD表现出均的纳米尺寸分布和针对药物输送的良好稳定性.
- 当光照射时,可以实现局部DNA损伤和STING激活.
- PFPD显著增强了自然杀手和T细胞的反应.
- 在体内观察到肺转移性瘤的有效根除,没有任何不良影响.
结论:
- PFPD为局部天生的免疫激活提供了一个复杂的策略.
- 这种方法显示了全身瘤治疗的潜力,并激发了精密疗法的纳米医学设计.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
